FDA expects no significant supply issues following tornado damage at Pfizer's North Carolina plant, starts mitigation steps for potential drug shortages; Pfizer puts product inventory on strict allocation to avoid hoarding, ensure equitable distribution

Sample article from our Logistic & Supply Chain

July 24, 2023 (press release) –

The Food and Drug Administration said it did not expect “any immediate significant impacts on supply” after a tornado damaged a Pfizer plant in North Carolina that makes sterile injectables for U.S. hospitals, but is working with Pfizer to complete a more extensive assessment and will share more information as it becomes available.

The agency said its initial analysis has identified fewer than 10 drugs for which the plant is the sole source for the U.S. market, adding that “a number of these are specific formulations for which there should be substitutes or for which many weeks’ worth of stock should be available in Pfizer’s other warehouses. For those products produced at this facility that are already in, or may be, at risk of shortage, the FDA has initiated mitigation steps, such as looking for additional sources and asking other manufacturers to prepare to ramp up production, if needed. To have equitable distribution of the products and ensure availability to those in most need, as well as to avoid hoarding, Pfizer has put the inventory of many products on strict allocation. These allocation measures could lead to localized supply disruptions depending on contractual relationships for supplies. Health care systems that have trouble in obtaining a particular drug should contact their distributor or Pfizer directly.”

AHA is watching the situation closely, because several of the drugs produced at the plant were on the FDA’s shortage list before the tornado struck.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order logistic & supply chain coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.